Skip to main content
BEAM logo

BEAM · Beam Therapeutics Inc.

Track BEAM — free
$26.75 +0.24 (+0.91%) At close · Aug 14
Market Cap
$2.76B
Shares
103.29M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
John Evans $5,818,525
Giuseppe Ciaramella $3,160,279
Amy Simon $2,802,044
Christine Bellon $1,967,177
Sravan Emany $1,296,528
Sravan K. Emany $1,296,528
Fiscal 2024
Executive Total
John Evans $6,409,631
Sravan K. Emany $4,818,306
Sravan Emany $4,818,306
Giuseppe Ciaramella $3,378,647
Terry-Ann Burrell $2,768,161
Amy Simon $2,615,681
Christine Bellon $2,581,460
Fiscal 2023
Executive Total
John Evans $6,280,099
Giuseppe Ciaramella $2,785,194
Terry-Ann Burrell $2,557,844
Former CFO $2,557,844
Amy Simon $2,545,219
Christine Bellon $2,281,013
Fiscal 2022
Executive Total
John Evans $9,496,745
Giuseppe Ciaramella $3,169,575
Terry-Ann Burrell $2,947,530
Former CFO $2,947,530
Fiscal 2021
Executive Total
John Evans $13,911,975
Giuseppe Ciaramella $5,535,622
Terry-Ann Burrell $3,938,904
Fiscal 2020
Executive Total
Giuseppe Ciaramella $6,852,786
John Evans $906,768
Terry-Ann Burrell $683,752
Fiscal 2019
Executive Total
Terry-Ann Burrell $4,302,723
John Evans $2,209,800
Giuseppe Ciaramella $1,588,450

Executive changes

Person Change Filed
Carole Ho Resigned 2026-02-05
Sravan K. Emany Appointed 2024-12-06
Chirfi Guindo Appointed 2024-12-04
John Evans Appointed 2024-07-15
Terry-Ann Burrell Resigned 2024-07-15
Terry-Ann Burrell Resigned 2024-07-15
Christi Shaw Appointed 2023-12-14
Key facts CIK 1745999 CUSIP 07373V105 13F (30d) 269 filings 261 filers Visit website Investor relations